HEART TRANSPLANTATION IN ACUTE DILATED CARDIOMYOPATHY IN THE OUTCOME OF CYTOMEGALOVIRUS MYOCARDITIS
Abstract
Aim: to describe the clinical observation of orthotopic heart transplantation in acute dilated cardiomyopathy in the outcome of cytomegalovirus myocarditis.
Methods. An analysis of the literature and a description of their own clinical observation of orthotopic heart transplantation in acute dilated cardiomyopathy in the outcome of cytomegalovirus myocarditis was carried out.
Results. Secondary dilated cardiomyopathy can occur in the outcome of various diseases, including viral myocarditis. If such patients develop chronic heart failure with a reduced ejection fraction, as well as life-threatening cardiac arrhythmias, there are indications for orthotopic heart transplantation. A clinical observation of orthotopic heart transplantation in acute dilated cardiomyopathy in the outcome of cytomegalovirus myocarditis is presented.
Conclusion. The presented clinical observation demonstrates the modern active cardiac surgical tactics of managing patients with terminal chronic heart failure.
References
2. Мареев В.Ю., Фомин И.В., Агеев Ф.Т. и др. Клинические рекомендации ОССН – РКО – РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН) Диагностика, профилактика и лечение //
Кардиология. 2018. Т. 58. №6s. С.8-158.
3. Azad A.K., Ahmed T., Chowdhury A.J., et al. Cytomegalovirus induced hepatitis in an immunocompetent host // Mymensingh Med J. 2008. Vol. 17(2 Suppl). P.S104-106.
4. Fernández-Ruiz M., Muñoz-Codoceo C., López-Medrano F., et al. Cytomegalovirus myopericarditis and hepatitis in an immunocompetent adult: successful treatment with oral valganciclovir // Intern Med. 2008. Vol. 47. №22. P.1963-1966.
5. Magno Palmeira M., Umemura Ribeiro H.Y., Garcia Lira Y., et al. Heart failure due to cytomegalovirus myocarditis in immunocompetent young adults: a case report // BMC Res Notes. 2016. Vol. 9. P.391. DOI: 10.1186/s13104-016-2181-5.
6. Nowalany-Kozielska E., Kozieł M., Domal-Kwiatkowska D., et al. Clinical Significance of Viral Genome Persistence in the Myocardium of Patients with Dilated Cardiomyopathy// Intervirology. 2015. Vol. 58. №6. P.350-356. DOI: 10.1159/000443375.
7. Padala S.K., Kumar A., Padala S. Fulminant cytomegalovirus myocarditis in an immunocompetent host: resolution with oral valganciclovir // Tex Heart Inst J. 2014. Vol. 41. №5. P.523-529. DOI: 10.14503/THIJ-13-3504.
8. Roubille C., Brunel A.S., Gahide G., et al. Cytomegalovirus (CMV) and acute myocarditis in an immunocompetent patient // Intern Med. 2010. Vol. 49. №2. P.131-133.
9. Vanstechelman F., Vandekerckhove H. Cytomegalovirus myocarditis in an immunocompetent patient // ActaCardiol. 2012. Vol. 67. №2. P.257-260.
REFERENCES
1. Belenkov Yu.Η., MareevV.Yu., Ageev F.T., Danielyan Μ.O. The first results of a national epidemiological study – an epidemiological examination of patients with CHF in actual clinical practice (referral) – EPOCHA-O-CHF // Zhurnal
serdechnaya nedostatochnost’. 2003. Vol. 4. №3. P.116-121. (in Russian)
2. Mareev V.Yu., Fomin I.V., Ageev F.T., et al. Clinical recommendations OSSN – RKO – RNMOT. Heart failure: chronic (CHF) and acute decompensated (HFH) Diagnosis, prevention and treatment // Kardiologiya. 2018. Vol. 58. №6s. P.8-158. (in
Russian)
3. Azad A.K., Ahmed T., Chowdhury A.J., et al. Cytomegalovirus induced hepatitis in an immunocompetent host // Mymensingh Med J. 2008. Vol. 17(2 Suppl). P.S104-106.
4. Fernández-Ruiz M., Muñoz-Codoceo C., López-Medrano F., et al. Cytomegalovirus myopericarditis and hepatitis in an immunocompetent adult: successful treatment with oral valganciclovir // Intern Med. 2008. Vol. 47. №22. P.1963-1966.
5. Magno Palmeira M., Umemura Ribeiro H.Y., Garcia Lira Y., et al. Heart failure due to cytomegalovirus myocarditis in immunocompetent young adults: a case report // BMC Res Notes. 2016. Vol. 9. P.391. DOI: 10.1186/s13104-016-2181-5.
6. Nowalany-Kozielska E., Kozieł M., Domal-Kwiatkowska D., et al. Clinical Significance of Viral Genome Persistence in the Myocardium of Patients with Dilated Cardiomyopathy// Intervirology. 2015. Vol. 58. №6. P.350-356. DOI: 10.1159/000443375.
7. Padala S.K., Kumar A., Padala S. Fulminant cytomegalovirus myocarditis in an immunocompetent host: resolution with oral valganciclovir // Tex Heart Inst J. 2014. Vol. 41. №5. P.523-529. DOI: 10.14503/THIJ-13-3504.
8. Roubille C., Brunel A.S., Gahide G., et al. Cytomegalovirus (CMV) and acute myocarditis in an immunocompetent patient // Intern Med. 2010. Vol. 49. №2. P.131-133.
9. Vanstechelman F., Vandekerckhove H. Cytomegalovirus myocarditis in an immunocompetent patient // ActaCardiol. 2012. Vol. 67. №2. P.257-260.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.